Skip to main content
. 2016 Sep 13;14(5):4124–4134. doi: 10.3892/mmr.2016.5735

Figure 2.

Figure 2.

Changes in levels of LOX-1 in NRK-52E cells following treatment with FK506 and ox-LDL. Immunofluorescence showing the expression of lectin-like ox-LDL receptor-1 in the (A) ox-LDL group (80 µg/ml for 48 h). (B) FK506 group (50 µg/ml for 48 h). (C) ox-LDL+FK506 group (80 µg/ml ox-LDL+50 µg/ml FK506 for 48 h) and (D) control group. Original magnification, ×200. ox-LDL, oxidized low-density lipoprotein; FK506, tacrolimus.